NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DenovAI Biotech

DenovAI Biotech

Private
IsraelHealthcare & Life Scienceshttps://denovai.com/

Last Round

Seed

Jan 8, 2024

Total Funding Raised

$2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DenovAI Biotech is a biotechnology company that develops a generative artificial intelligence and physics platform for the de-novo design of therapeutic proteins, including antibodies and mini-proteins.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

antibody discoveryde novo antibody designAI drug discoveryin silico drug designgenerative AIprotein binder designbiologics discoverymolecular biophysicstherapeutic antibodydrug discovery platformAI-first biotechcomputational biologypharma R&DtechbioAI-driven discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DenovAI Biotech Comps

Public and private peers based on sector, stage, and business model.

DenovAI Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DenovAI Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 8, 2024
Pre SeedFeb 28, 2023

Key People

Founding team and executive leadership

Kashif Sadiq

Founder CEO

Founding Team

Tal Leibovich-Rivkin

COO

Executive Team

DenovAI Biotech Investors

Notable investors and investment history

DenovAI Biotech investors
InvestorRounds
Israel Biotech FundSeed, Pre Seed
Israel Innovation AuthorityGrant
Amiti VenturesSeed, Pre Seed
PfizerSeed, Pre Seed
AION LabsSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 249% MoM, reaching 2K.

DenovAI Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DenovAI Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DenovAI Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range11
Year Founded2023
Last FundingJan 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.